The portfolio maintains a cost advantage over competitors, priced within the least expensive fee quintile among peers.
IQ Healthy Hearts ETF HART
Morningstar’s Analysis HART
Will HART outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 50.1
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Alphabet Inc Class A | 5.64 | 490,094 | Communication Services |
AstraZeneca PLC | 5.56 | 483,334 | Healthcare |
Novo Nordisk A/S Class B | 5.27 | 457,342 | Healthcare |
Eli Lilly and Co | 4.94 | 429,291 | Healthcare |
Pfizer Inc | 4.92 | 427,014 | Healthcare |
UnitedHealth Group Inc | 4.84 | 420,493 | Healthcare |
Novartis AG Registered Shares | 4.79 | 416,068 | Healthcare |
Johnson & Johnson | 4.79 | 415,896 | Healthcare |
Apple Inc | 4.72 | 410,122 | Technology |
Abbott Laboratories | 4.66 | 404,618 | Healthcare |